Table 3 Cumulative effect of the 4 nominally significant SNPs between KD patients and normal controls
No. of non-risk genotypes | KD cases (%) | Controls (%) | OR | 95%CI | P † |
|---|---|---|---|---|---|
0 | 61 (14.88) | 49 (10.49) | Ref. | Ref. | |
1 | 178 (43.41) | 181 (38.76) | 0.79 | 0.52–1.22 | 0.288 |
2 | 153 (37.32) | 184 (39.40) | 0.67 | 0.43–1.03 | 0.069 |
3~4 | 18 (4.39) | 53 (11.35) | 0.27 | 0.14–0.53 | <0.001 |
Cochran-Armitage Trend Test | <0.001 |